Zobrazeno 1 - 10
of 129
pro vyhledávání: '"Peter G, Zaphiropoulos"'
Autor:
Yumei Diao, Mohammed Ferdous‐Ur Rahman, Yuri Vyatkin, Ani Azatyan, Georges St. Laurent, Philipp Kapranov, Peter G. Zaphiropoulos
Publikováno v:
Molecular Oncology, Vol 12, Iss 10, Pp 1718-1734 (2018)
Hedgehog (HH) signaling is involved in many physiological processes, and pathway deregulation can result in a wide range of malignancies. Glioma‐associated oncogene 1 (GLI1) is a transcription factor and a terminal effector of the HH cascade. Despi
Externí odkaz:
https://doaj.org/article/fd8f7677fd4f4dadae21d24e3b850489
Autor:
Ani Azatyan, Peter G. Zaphiropoulos
Publikováno v:
Cancers; Volume 14; Issue 13; Pages: 3134
Background. The cerebellar cancer medulloblastoma is the most common childhood cancer in the brain. Methods. RNA sequencing of 81 human biospecimens of medulloblastoma using pipelines to detect circular and fusion RNAs. Validation via PCR and Sanger
Autor:
Ani Azatyan, Chunyan Zhao, Peter G. Zaphiropoulos, Yumei Diao, Jian Zhu, Mohammed Ferdous-Ur Rahman, Karin Dahlman-Wright
Publikováno v:
Oncotarget
// Yumei Diao 1 , Ani Azatyan 1 , Mohammed Ferdous-Ur Rahman 1 , Chunyan Zhao 1 , Jian Zhu 1 , Karin Dahlman-Wright 1 , Peter G. Zaphiropoulos 1 1 Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden Correspondence to: Pet
Autor:
Ulrica Tostar, Csaba Finta, Mohammed Ferdous-Ur Rahman, Takashi Shimokawa, Peter G Zaphiropoulos
Publikováno v:
PLoS ONE, Vol 7, Iss 5, p e37761 (2012)
The Suppressor of Fused (SUFU) protein plays an essential role in the Hedgehog (HH) signaling pathway, by regulation of the GLI transcription factors. Two major isoforms of human SUFU are known, a full-length (SUFU-FL) and a carboxy-terminal truncate
Externí odkaz:
https://doaj.org/article/ee450d94fb0d42eb9854702ee3d739c3
Autor:
Peter G. Zaphiropoulos, Philipp Kapranov, Georges St. Laurent, Ani Azatyan, Yumei Diao, Mohammed Ferdous-Ur Rahman, Yuri Vyatkin
Publikováno v:
Molecular Oncology
Molecular Oncology, Vol 12, Iss 10, Pp 1718-1734 (2018)
Molecular Oncology, Vol 12, Iss 10, Pp 1718-1734 (2018)
Hedgehog (HH) signaling is involved in many physiological processes, and pathway deregulation can result in a wide range of malignancies. Glioma‐associated oncogene 1 (GLI1) is a transcription factor and a terminal effector of the HH cascade. Despi
Publikováno v:
Cancers
Volume 13
Issue 20
Cancers, Vol 13, Iss 5138, p 5138 (2021)
Volume 13
Issue 20
Cancers, Vol 13, Iss 5138, p 5138 (2021)
Simple Summary Here the expression profile of circular RNAs in Hedgehog signaling-dependent cell lines and medulloblastoma cells was interrogated. Using stringent criteria, a reduced expression of seven circular RNAs in Hedgehog-dependent medulloblas
Autor:
Galina Selivanova, Yumei Diao, Ani Azatyan, Peter G. Zaphiropoulos, Gabriel Gallo-Oller, John Inge Johnsen
Publikováno v:
Cancer letters. 442
Overactivation of the Hedgehog (HH) signaling pathway is implicated in many cancers. In this study, we demonstrate that the small molecule RITA, a p53 activator, effectively downregulates HH signaling in human medulloblastoma and rhabdomyosarcoma cel
Publikováno v:
International Journal of Molecular Sciences, Vol 16, Iss 2, Pp 3251-3266 (2015)
International Journal of Molecular Sciences
International Journal of Molecular Sciences
Antisense transcription, considered until recently as transcriptional noise, is a very common phenomenon in human and eukaryotic transcriptomes, operating in two ways based on whether the antisense RNA acts in cis or in trans. This process can genera
Autor:
Peter G. Zaphiropoulos, Mona Ståhle, Enikö Sonkoly, Ulrica Tostar, Takashi Shimokawa, Ramesh Palaniswamy, Andor Pivarcsi, Mohammed Ferdous-Ur Rahman
Publikováno v:
RNA Biology
The Hedgehog (HH) signaling pathway has important roles in tumorigenesis and in embryonal patterning. The Glioma-associated oncogene 1 (GLI1) is a key molecule in HH signaling, acting as a transcriptional effector and, moreover, is considered to be a
Autor:
Isabella Castellano, Anna Sapino, Victoria E. Villegas, Laura Annaratone, Adriana Grismaldo, Peter G. Zaphiropoulos, Milena Rondón-Lagos
Publikováno v:
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
International Journal of Molecular Sciences
International Journal of Molecular Sciences; Volume 17; Issue 3; Pages: 308
International Journal of Molecular Sciences, Vol 17, Iss 3, p 308 (2016)
Universidad del Rosario
instacron:Universidad del Rosario
International Journal of Molecular Sciences
International Journal of Molecular Sciences; Volume 17; Issue 3; Pages: 308
International Journal of Molecular Sciences, Vol 17, Iss 3, p 308 (2016)
The selective estrogen receptor (ER) modulator tamoxifen (TAM) has become the standard therapy for the treatment of ER+ breast cancer patients. Despite the obvious benefits of TAM, a proportion of patients acquire resistance to treatment, and this is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8e69a05475edb93789411bf76cc5f84
https://repository.urosario.edu.co/handle/10336/21353
https://repository.urosario.edu.co/handle/10336/21353